{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:17:26Z","timestamp":1780431446832,"version":"3.54.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Data on the safety of direct current cardioversion (DCCV) in patients with left atrial appendage occlusion (LAAO) devices and its impact on thromboembolic prevention are limited. This study aimed to investigate the safety and efficacy of DCCV in patients with LAAO devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, ambispective cohort included patients undergoing one-stop procedures [LAAO combined with radiofrequency catheter ablation (RFCA)], where LAAO was performed first. DCCV was performed to restore sinus rhythm after LAAO. Patients were divided into the DCCV group and the no-DCCV group. Safety endpoints included DCCV-related death, device dislodgment, device embolization, and major bleeding events. Efficacy endpoints contained all-cause death, cardiovascular death, stroke\/transient ischemic attack, and systemic embolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 196 patients (age 72.5\u2009\u00b1\u20097.4 years, 51.0% male) were enrolled, with 95 patients undergoing DCCV after LAAO. No DCCV-related death, device dislodgement, or device embolism was observed. At 12 months, the safety endpoints occurred in 3.2% of the DCCV group vs. 6.9% of the no-DCCV group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.238). Similarly, the efficacy endpoints were observed in 1.1% of the DCCV group vs. 4.0% of the no-DCCV group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.339). By performing pre- and post-DCCV transesophageal echocardiography (TEE) in the prospective cohort, a significant increase in device diameter at 45\u00b0 and 90\u00b0 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.044; 0.027), and an insignificant decline trend of peri-device leak and shoulder at 135\u00b0 were noted (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.051; 0.103).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No signal of excess risk was observed when performing DCCV in patients with LAAO devices. Tiny changes in device diameter after DCCV were noted on TEE at 45\u00b0 and 90\u00b0, but these were not associated with adverse effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1604268","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:25:58Z","timestamp":1762323958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Direct current cardioversion of atrial fibrillation in patients with left atrial appendage occlusion devices"],"prefix":"10.3389","volume":"12","author":[{"given":"Xin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/circulationaha.122.062765","article-title":"Comparative effectiveness of left atrial appendage occlusion versus oral anticoagulation by sex","volume":"147","author":"Zeitler","year":"2023","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/europace\/euaa057","article-title":"Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure","volume":"22","author":"Brandes","year":"2020","journal-title":"Europace"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/europace\/euy025","article-title":"Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry","volume":"20","author":"Wintgens","year":"2018","journal-title":"Europace"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1111\/jce.15230","article-title":"The long-term efficacy and safety of combining ablation and left atrial appendage closure: a systematic review and meta-analysis","volume":"32","author":"Li","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.jacc.2019.08.1045","article-title":"Direct current cardioversion of atrial fibrillation in patients with left atrial appendage occlusion devices","volume":"74","author":"Sharma","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/jce.13289","article-title":"Long-term follow-up after left atrial appendage occlusion with comparison of transesophageal echocardiography versus computed tomography to guide medical therapy and data about postclosure cardioversion","volume":"28","author":"Berte","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jcin.2014.05.026","article-title":"Percutaneous left atrial appendage closure: procedural techniques and outcomes","volume":"7","author":"Saw","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"B9","doi-asserted-by":"publisher","first-page":"690297","DOI":"10.3389\/fcvm.2021.690297","article-title":"Prevalence and predictors of additional ablation beyond pulmonary vein isolation in patients with paroxysmal atrial fibrillation","volume":"8","author":"Xie","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2016.02.056","article-title":"Validation of BARC bleeding criteria in patients with acute coronary syndromes: the TRACER trial","volume":"67","author":"Vranckx","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/eurheartj\/ehz585","article-title":"Maximum-fixed energy shocks for cardioverting atrial fibrillation","volume":"41","author":"Schmidt","year":"2020","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/ehjci\/jeac222","article-title":"Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing?","volume":"24","author":"Kramer","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/ehjci\/jev067","article-title":"Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure","volume":"16","author":"Saw","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jama.2022.23722","article-title":"Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial","volume":"329","author":"Kistler","year":"2023","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ahj.2021.10.182","article-title":"Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic events","volume":"244","author":"Rasmussen","year":"2022","journal-title":"Am Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00392-014-0724-0","article-title":"Thromboembolic stroke after cardioversion with incomplete left atrial appendage closure","volume":"103","author":"Hanazawa","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.joa.2015.11.001","article-title":"Combined catheter ablation for atrial fibrillation and Watchman\u00ae left atrial appendage occlusion procedures: five-year experience","volume":"32","author":"Phillips","year":"2016","journal-title":"J Arrhythm"},{"key":"B19","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/jce.14889","article-title":"Impact of anticoagulation strategy after left atrial appendage occlusion in patients requiring direct current cardioversion","volume":"32","author":"Maarse","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jcin.2010.04.017","article-title":"Left atrial appendage obliteration: mechanisms of healing and intracardiac integration","volume":"3","author":"Schwartz","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.4244\/eij-d-21-01033","article-title":"Post-release shift with watchman FLX devices during left atrial appendage closure: the \u201cpopcorn effect\u201d","volume":"18","author":"Silva","year":"2022","journal-title":"EuroIntervention"},{"key":"B22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-year outcomes after left atrial appendage closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/europace\/euw141","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2016","journal-title":"Europace"},{"key":"B24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10554-022-02721-w","article-title":"Clinical relevance of incomplete device endothelialization after left atrial appendage closure","volume":"39","author":"Xu","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"B25","first-page":"245","article-title":"Occurrence of incomplete endothelialization causing residual permeability after left atrial appendage closure","volume":"30","author":"Granier","year":"2018","journal-title":"J Invasive Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1604268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:25:59Z","timestamp":1762323959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1604268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2025.1604268"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1604268","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"article-number":"1604268"}}